Literature DB >> 8937137

[Analysis of body composition by dual energy X-ray absorptiometry and its relation to pulmonary function in patients with pulmonary emphysema].

M Yoshikawa1, T Yoneda, A Fu, C Yamamoto, H Takenaka, M Nakaya, A Kobayashi, T Tokuyama, Y Okamoto, N Narita.   

Abstract

The purpose of this study was to investigate body composition in patients with chronic obstructive pulmonary disease, and its relation to pulmonary function. Seventeen men with pulmonary emphysema who were being treated as outpatients were divided into three groups, according to ideal body weight (IBW): group A, %IBW > or = 90%; group B, 90 > %IBM > or = 80; and group C, %IBW < 80. All underwent body composition analysis by dual energy X-ray absorptiometry. Fat mass and bone mineral content were significantly lower in groups B and C than in control subjects. Lean mass was significantly lower in group C than in control subjects. By contrast, group A did not differ significantly from control subjects. Lean mass correlated significantly with %VC, FEV1, RV/TLC, and MVV. These data suggest that lean mass is low in moderately and severely malnourished patients, that bone mineral content and fat mass are low in mildly malnourished patients, and that abnormal body composition is associated with ventilatory impairment in patients with chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  1996        PMID: 8937137

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  2 in total

1.  The Relationship of Energy Malnutrition, Skeletal Muscle and Physical Functional Performance in Patients with Stable Chronic Obstructive Pulmonary Disease.

Authors:  Manabu Tomita; Masaru Uchida; Yujiro Imaizumi; Megumi Monji; Emiko Tokushima; Michihiro Kawashima
Journal:  Nutrients       Date:  2022-06-23       Impact factor: 6.706

2.  Effects of acupuncture on nutritional state of patients with stable chronic obstructive pulmonary disease (COPD): re-analysis of COPD acupuncture trial, a randomized controlled trial.

Authors:  Masao Suzuki; Shigeo Muro; Motonari Fukui; Naoto Ishizaki; Susumu Sato; Tetsuhiro Shiota; Kazuo Endo; Tomoko Suzuki; Tadamichi Mitsuma; Michiaki Mishima; Toyohiro Hirai
Journal:  BMC Complement Altern Med       Date:  2018-10-24       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.